Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver-directed gene therapy: prospects and problems

M Strauss1

  • 1Max-Planck-Gesellschaft, Humboldt Universität, Max-Delbrück-Center for Molecular Medicine, Berlin-Buch, Germany.

Gene Therapy
|May 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of top quark polarization in top-antitop events from proton-proton collisions at √s=7  TeV using the ATLAS detector.

Physical review letters·2014
Same author

Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013.

Clinical EEG and neuroscience·2013
Same author

Measurement of the azimuthal angle dependence of inclusive jet yields in Pb+Pb collisions at √(sNN)=2.76 TeV with the ATLAS detector.

Physical review letters·2013
Same author

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector.

Physical review letters·2013
Same author

Microcavity controlled coupling of excitonic qubits.

Nature communications·2013
Same author

Measurement of the semileptonic charge asymmetry using B(s)(0) → D(s)μX decays.

Physical review letters·2013
Same journal

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026
Same journal

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Gene therapy·2026
Same journal

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026
Same journal

Applications of genome editing technologies in the treatment of human diseases.

Gene therapy·2026
Same journal

High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

Gene therapy·2026
Same journal

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026
See all related articles

Developing in vivo gene therapy for liver diseases is crucial due to the liver's role in genetic, malignant, and infectious conditions. Current ex vivo methods have limitations, necessitating advancements in direct in vivo gene transfer techniques.

Area of Science:

  • Hepatology
  • Gene Therapy
  • Molecular Medicine

Background:

  • The liver is a primary site for genetic, malignant, and infectious diseases, making it a key target for therapeutic interventions.
  • Hepatocyte gene transfer has been explored using ex vivo approaches, but retransplantation faces significant limitations.
  • In vivo gene therapy offers a promising alternative to overcome the challenges associated with ex vivo hepatocyte manipulation.

Purpose of the Study:

  • To review the current state of gene therapy techniques for liver applications.
  • To evaluate the efficacy and limitations of existing viral and non-viral gene transfer vectors for in vivo use.
  • To identify essential future developments required for successful in vivo liver gene therapy.

Main Methods:

  • Review of existing literature on gene transfer methods in hepatocytes.

Related Experiment Videos

  • Analysis of viral and non-viral delivery systems tested in animal models for liver gene therapy.
  • Discussion of challenges and future directions in the field.

    • Main Results:

    • Ex vivo gene transfer to hepatocytes has been extensively studied but has practical limitations for patient application.
    • In vivo gene transfer strategies using both viral and non-viral vectors have shown limited success in preclinical models.
    • Significant challenges remain in achieving efficient and safe gene delivery directly to liver cells in vivo.

    Conclusions:

    • Effective in vivo gene therapy for liver diseases requires overcoming current delivery system limitations.
    • Further research into novel vectors and delivery strategies is essential for advancing liver gene therapy.
    • The development of robust in vivo gene transfer methods is critical for treating a wide range of liver pathologies.